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Abstract
The prevalence of myocardial involvement in influenza infection ranges from 0% to 11%
depending on the diagnostic criteria used to define myocarditis. Whether such an association
holds for the novel influenza A strain, pandemic-2009-H1N1, remains unknown. The clinical
presentation of myocarditis varies and often mimics myocardial infarction. Although history,
physical examination, laboratory data points, and electrocardiogram are helpful in distin-
guishing myocarditis from myocardial infarction, differential diagnosis can sometimes be
difficult. Here, we present the first known report of acute myocarditis mimicking acute myo-
cardial infarction associated with the pandemic influenza A virus (H1N1) infection. (Cardiol J
2011; 18, 5: 552–555)
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Introduction
Acute myocarditis is a well-recognized, albeit
rare, manifestation of numerous viral infections
with a broad spectrum of symptoms and clinical fea-
tures [1]. The prevalence of myocardial involve-
ment in influenza infection ranges from 0% to 11%,
depending on the diagnostic criteria used to define
myocarditis [2, 3]. Whether such an association
holds for the novel influenza A strain, pandemic-
-2009-H1N1, remains unknown.
A few case reports and series [4, 5] represent
the incidental diagnoses of influenza-associated
acute  myocarditis with the pandemic 2009-H1N1
influenza A virus infection, but the true prevalence
remains unknown.
Although, there are many case reports of acute
myocarditis mimicking [6–9] acute myocardial in-
farction, here we present the first known report of
acute myocarditis mimicking acute myocardial in-
farction associated with the pandemic H1N1 influ-
enza A virus infection.
Case report
A 34 year-old woman was admitted to our hos-
pital with moderate to severe retrosternal chest
pain, emerging six hours before, radiating to back.
The pain had an acute onset, progressive course and
a compressing nature. She perceived no changes in
the quality of pain with position or on inspiration.
Within the past week, she had experienced fever,
cough, sore throat, nausea and shortness of breath.
There was no history of smoking, diabetes, hyper-
tension, dyslipidemia, family history of coronary
artery disease or cocaine abuse. Her initial heart
rate was 92 beats/min; temperature 37.6°C, blood
pressure 112/72 mm Hg, and respiratory rate
24 breaths/min with an oxygen saturation of 94% on
room air. Cardiac examination revealed normal S1,
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S2, with no additional sounds, murmurs or pericar-
dial rub. The rest of the physical examination was
normal. Electrocardiogram (ECG) on admission re-
vealed sinus rhythm, normal QRS axis, a Q-wave
at leads II, III, aVF and ST-segment elevation at leads
II, III, aVF with reciprocal ST segment depression at
leads I, aVL (Fig. 1). On chest X-ray the heart size
was normal and there were no signs of pulmonary
pathology. Results of initial cardiac enzyme tests
revealed serum troponin I of 8.5 ng/mL (normal
< 1 ng/mL), creatine kinase (CK) of 272 U/L (nor-
mal 20–150 U/L), and CK-MB of 32.8 IU/L (normal
< 25 IU/L). The laboratory investigations were oth-
erwise normal except for elevated WBC (17200/mL)
and ESR (68 mm/h). Echocardiography, which was
done in the emergency department, showed a left
ventricle with normal internal dimensions, an ap-
parent regional hypokinesia of the posterior, mid-
dle and basal segments of the inferior wall with an
ejection fraction of 45%. There was no evidence of
pericardial thickening or effusion. The patient was
started on aspirin, intravenous metoprolol, heparin
and morphine therapy. The chest pain and ST ele-
vation persisted despite sublingual and intravenous
nitroglycerin administration, and she was taken as
an emergency to the cardiac catheterization labo-
ratory 30–35 min after admission. Coronary angio-
graphy showed normal epicardial coronary arte-
ries (Figs. 2, 3). The left ventricular end diastolic
pressure was 17 mm Hg. Her chest pain resolved
spontaneously within a few hours.
As the symptoms and clinical findings of the
patient fitted the criteria defined by World Health
Organization for the influenza (H1N1) pandemia
2009, we collected nasal wash specimens and these
were sent to the University of Istanbul Virology
Laboratory working as the National Influenza Re-
ference Laboratory (NIRL) in Turkey. Without wait-
ing for the laboratory test results, the patient was
treated with oseltamivir (Tamiflu, Roche, Basle,
Switzerland) 75 mg orally twice a day for five days. Over
the following days, a reverse-transcriptase polymerase
chain reaction test of NIRL showed a postitive result.
CK and CK-MB levels peaked on the 2nd day of hos-
pitalization at 835 IU/L and 189 IU/L respectively.
Over the following days, ST-segment elevations
gradually decreased and negative T-waves appeared
at the same leads and precordial leads (Fig. 4).
The patient was discharged on angiotensin-con-
verting-enzyme inhibitor and beta-blocker therapy
in good condition without chest pain. Two weeks
later, she remained asymptomatic and echocardio-
graphic assessment showed that the regional wall
motion abnormality was greatly improved.
Discussion
Influenza A virus-associated myocarditis is
rare, with only a few cases reported in the litera-
ture [2]. Here, we present the first known report
of acute myocarditis mimicking acute myocardial
infarction associated with the 2009 pandemic influ-
enza A virus (H1N1) infection.
The prevalence of influenza-associated myo-
carditis is not known because of a lack of compre-
hensive screening, with only a handful of clinical
cases and autopsy findings reported in the litera-
ture [2, 3]. Whether such an association holds for
the novel influenza A strain, pandemic-2009-H1N1,
remains unknown.
Martin et al. [4] reviewed 123 sequential cas-
es of patients hospitalized with pandemic-2009-
-H1N1 influenza A at a single academic medical cent-
er in the United States between April 1 and Octo-
ber 31, 2009. They identified that 4.9% (6/123) of
patients had either new or worsened left ventricu-
lar dysfunction. Two thirds (4/6) of the cases had
follow-up echocardiograms, and in all four left ven-
tricular function improved. Therefore, they found
that potentially reversible cardiac dysfunction is
a relatively common complication associated with
hospitalized pandemic-2009-H1N1 influenza. In our
case, we also found that left ventricular function was
highly improved in follow-up.
Bratincsak et al. [5] documented four cases
within a 30-day period in 2010. Comparing them to
their previous experience, they declared that it was
possible that H1N1 influenza A virus was more com-
monly associated with a severe form of myocardi-
tis than previously encountered influenza strains,
and that those observations warranted a high index
of suspicion for myocarditis in children with H1N1
influenza A infection.
However,  there are many case reports of acute
myocarditis mimicking acute myocardial infarction
[6–9]. A thorough and detailed history, examination
and ECG interpretation by an expert cardiologist is
mandatory in this situation to avoid complications
that may arise from inaccurate diagnosis. Despite
a low cardiac risk score supportinga diagnosis of myo-
carditis in our patient, the localized dramatic infe-
rior ST-segment elevation and segmental left ven-
tricular dysfunction raised the possibility of an acute
coronary syndrome. Differential diagnosis often re-
quires cardiac catheterization. Diagnosis in these
kinds of patients is difficult, as they may not have
an acute coronary syndrome. A diagnosis of myo-
carditis needs to be kept in mind. Unfortunately, the
clinical diagnosis of myocarditis remains a challenge
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Figure 1. A. Electrocardiogram on admission revealed Q-wave at leads II, III, aVF and ST-segment elevation at leads
II, III, aVF with reciprocal ST segment depression at leads I, aVL; B. Electrocardiogram on discharge revealed
ST-segment elevations gradually decreased and negative T-waves appeared at the same leads and precordial leads.
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Figure 2. A. Left coronary angiogram in a right anterior oblique-cranial projection shows no significant coronary
artery disease; B. Right coronary angiogram shows no significant coronary artery disease.
owing to the non-specific pattern of the clinical pre-
sentation and the lack of universally accepted and
standardized diagnostic criteria. Primary percuta-
neous coronary intervention should always be the
treatment of choice, since all of the preliminary
signs and test results may be confused with acute
myocardial infarction.
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